Aaron Lech
Optometrist · Roseville, CANPI 1053365254
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $68,125 of the $99,842 with a category attached, or 68.2%. Carl Zeiss Meditec, Inc. accounts for 93.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $37,607 and has fallen 91.1% since, to $3,365 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $708.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$93K
- AbbVie$3K
- Novo Nordisk AS$2K
- Carl Zeiss Meditec USA, Inc.$1K
- Tarsus Pharmaceuticals, Inc.$521
- Johnson & Johnson Vision Care, Inc.$227
- plus $554 from 11 others
Across 4 payments — averaging $3447.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$14K
What the payments were for
- Consulting fees$68,12568%
- Speaking & faculty fees$19,10019%
- Travel & lodging$7,6958%
- Food & beverage$4,9225%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 73 | $93,115 |
| AbbVie(2 entities) | 10 | $2,508 |
| Novo Nordisk AS | 4 | $1,790 |
| Carl Zeiss Meditec USA, Inc. | 12 | $1,127 |
| Tarsus Pharmaceuticals, Inc. | 7 | $521 |
| Johnson & Johnson Vision Care, Inc. | 11 | $227 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $116 |
| Bausch & Lomb Americas Inc. | 6 | $113 |
| Sun Pharmaceutical Industries Inc. | 2 | $64 |
| Genentech USA, Inc. | 1 | $54 |
| Glaukos Corporation | 1 | $52 |
| Alcon | 2 | $36 |
| Biotissue Holdings Inc. | 2 | $34 |
| Coopervision Inc. | 1 | $30 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $26 |
| Maculogix, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$41,350
- FORUM$38,457
- CLARUS$36,219
- CIRRUS 6000 with AngioPlex$26,000
- FORUM Glaucoma Workplace$26,000
- Humphrey Field Analyzer (HFA3)$26,000
- Retina Workplace$26,000
- CLARUS 500 Fundus Camera$22,741
- Humphrey HFA$21,625
- Glaucoma Workplace$6,054
- VisuMax$4,400
- IOLMaster$2,000
- CLARUS 500$1,862
- RESTASIS MULTIDOSE$1,306
- ATLAS 500$1,200
- CALLISTO eye$1,200
- LUMIGAN$1,007
- COMBIGAN$1,007
- ALPHAGAN P$875
- XDEMVY$456
How this compares
$99,842 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 11 | $2,157 |
| Loteprednol Etabonate | 24 | $2,107 |
| Latanoprost | 79 | $590 |
| Timolol Maleate | 21 | $147 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $116 | $2,10724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,778 optometrist providers in California.
Other optometrist in Roseville
- Lisa HornickRoseville$35K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.